The effect of the composition of a fixed dose combination on bioequivalence results

[Display omitted] The purpose of this work was to develop a new supergeneric product Meloxicam/Omeprazole. Such a combination brings a benefit in terms of decreasing side effects for the patients using meloxicam. The new combination is composed of a meloxicam powder blend (MPB) and omeprazole gastro...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of pharmaceutics 2018-07, Vol.546 (1-2), p.235-246
Hauptverfasser:	Šalandová, Jana, Franc, Aleš, Hofmann, Jiří, Dumicic, Aleksandra, Kukačková, Lenka, Červená, Tereza, Beránek, Josef, Srbek, Jan, Repický, Andrej, Vladovičová, Beata, Vetchý, David
Format:	Artikel
Sprache:	eng
Schlagworte:	Bioequivalence study Biorelevant dissolution Meloxicam Omeprazole Supergeneric product
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!